205 related articles for article (PubMed ID: 26350528)
1. Intravitreal Steroids for the Prevention of PVR After Surgery for Retinal Detachment.
Gagliano C; Toro MD; Avitabile T; Stella S; Uva MG
Curr Pharm Des; 2015; 21(32):4698-702. PubMed ID: 26350528
[TBL] [Abstract][Full Text] [Related]
2. Prophylactic intravitreal 5-fluorouracil and heparin to prevent proliferative vitreoretinopathy in high-risk patients with retinal detachment: study protocol for a randomized controlled trial.
Schaub F; Hoerster R; Schiller P; Felsch M; Kraus D; Zarrouk M; Kirchhof B; Fauser S
Trials; 2018 Jul; 19(1):384. PubMed ID: 30012187
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for proliferative vitreoretinopathy.
Nagasaki H; Shinagawa K; Mochizuki M
Prog Retin Eye Res; 1998 Jan; 17(1):77-98. PubMed ID: 9537796
[TBL] [Abstract][Full Text] [Related]
4. Influence of intravitreal triamcinolone acetonide injection in scleral buckling surgery for macula-off retinal detachment.
Mirshahi A; Karkhaneh R; Zamani Amir J; Movassat M; Azadi P
Ophthalmic Res; 2014; 52(3):160-4. PubMed ID: 25342193
[TBL] [Abstract][Full Text] [Related]
5. [Proliferative vitreoretinopathy prophylaxis : Mission (im)possible].
Schaub F; Abdullatif AM; Fauser S
Ophthalmologe; 2021 Jan; 118(1):3-9. PubMed ID: 32666172
[TBL] [Abstract][Full Text] [Related]
6. Steroid Drugs as an Adjunct for Reducing the Incidence of Proliferative Vitreoretinopathy after Rhegmatogenous Retinal Detachment Surgery: A Meta-Analysis of Randomized Controlled Studies.
Xu M; Fan X; Huang X; Chen X; Shao Y; Li X
Ophthalmic Res; 2023; 66(1):599-610. PubMed ID: 36754031
[TBL] [Abstract][Full Text] [Related]
7. Intravitreal low molecular weight heparin and 5-Fluorouracil for the prevention of proliferative vitreoretinopathy following retinal reattachment surgery.
Sundaram V; Barsam A; Virgili G
Cochrane Database Syst Rev; 2010 Jul; (7):CD006421. PubMed ID: 20614445
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal Injection of Bevacizumab for the Prevention of Postoperative Proliferative Vitreoretinopathy in High-Risk Patients Selected by Laser Flare Photometry.
Gahon M; Luc A; Zessler A; Pastor G; Angioi-Duprez K; Thilly N; Berrod JP; Conart JB
Ophthalmologica; 2023; 246(5-6):306-313. PubMed ID: 37769629
[TBL] [Abstract][Full Text] [Related]
9. Intravitreal 5-Fluorouracil and Heparin to Prevent Proliferative Vitreoretinopathy: Results from a Randomized Clinical Trial.
Schaub F; Schiller P; Hoerster R; Kraus D; Holz FG; Guthoff R; Agostini H; Spitzer MS; Wiedemann P; Lommatzsch A; Boden KT; Dimopoulos S; Bemme S; Tamm S; Maier M; Roider J; Enders P; Altay L; Fauser S; Kirchhof B;
Ophthalmology; 2022 Oct; 129(10):1129-1141. PubMed ID: 35680097
[TBL] [Abstract][Full Text] [Related]
10. Anterior chamber aqueous flare is a strong predictor for proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
Schröder S; Muether PS; Caramoy A; Hahn M; Abdel-Salam M; Diestelhorst M; Kirchhof B; Fauser S
Retina; 2012 Jan; 32(1):38-42. PubMed ID: 21765375
[TBL] [Abstract][Full Text] [Related]
11. Steroids as an adjunct for reducing the incidence of proliferative vitreoretinopathy after rhegmatogenous retinal detachment surgery: a systematic review and meta-analysis.
Shi H; Guo T; Liu PC; Wang QY; Du YR; Liu QY; He MM; Liu JL; Yu J
Drug Des Devel Ther; 2015; 9():1393-400. PubMed ID: 25834397
[TBL] [Abstract][Full Text] [Related]
12. [Multimodal Approaches for the Analysis of Retinal Functional Disorders―Focusing on Retinal Detachment].
Terasaki H
Nippon Ganka Gakkai Zasshi; 2017 Mar; 121(3):185-231. PubMed ID: 30088405
[TBL] [Abstract][Full Text] [Related]
13. [Triamcinolone acetonide in the prevention of experimental proliferative vitreoretinopathy].
Liang HC; Hui YN; Cai YS
Zhonghua Yan Ke Za Zhi; 1994 Mar; 30(2):122-4. PubMed ID: 8001444
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for proliferative vitreoretinopathy.
Nagasaki H; Shinagawa K
Curr Opin Ophthalmol; 1995 Jun; 6(3):70-5. PubMed ID: 10150873
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and risk factors for proliferative vitreoretinopathy in eyes with rhegmatogenous retinal detachment but no previous vitreoretinal surgery.
Tseng W; Cortez RT; Ramirez G; Stinnett S; Jaffe GJ
Am J Ophthalmol; 2004 Jun; 137(6):1105-15. PubMed ID: 15183797
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive intraocular and peri-ocular steroid (triamcinolone acetonide) versus standard treatment in eyes undergoing vitreoretinal surgery for open globe trauma (ASCOT): study protocol for a phase III, multi-centre, double-masked randomised controlled trial.
Banerjee PJ; Cornelius VR; Phillips R; Lo JW; Bunce C; Kelly J; Murphy C; Edwards RT; Robertson EL; Charteris DG
Trials; 2016 Jul; 17(1):339. PubMed ID: 27449500
[TBL] [Abstract][Full Text] [Related]
17. Intercellular adhesion molecule-1 in proliferative vitreoretinopathy.
Limb GA; Chignell AH; Cole CJ; Green WT; Webster L; Hollifield RD; Dumonde DC
Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):1043-8. PubMed ID: 9113001
[TBL] [Abstract][Full Text] [Related]
18. A brief review of the histopathology of proliferative vitreoretinopathy (PVR).
Mudhar HS
Eye (Lond); 2020 Feb; 34(2):246-250. PubMed ID: 31792351
[TBL] [Abstract][Full Text] [Related]
19. Triamcinolone acetonide in silicone-filled eyes as adjunctive treatment for proliferative vitreoretinopathy: a randomized clinical trial.
Ahmadieh H; Feghhi M; Tabatabaei H; Shoeibi N; Ramezani A; Mohebbi MR
Ophthalmology; 2008 Nov; 115(11):1938-43. PubMed ID: 18584876
[TBL] [Abstract][Full Text] [Related]
20. Validity of aqueous flare measurement in predicting proliferative vitreoretinopathy in patients with rhegmatogenous retinal detachment.
Conart JB; Kurun S; Ameloot F; Tréchot F; Leroy B; Berrod JP
Acta Ophthalmol; 2017 Jun; 95(4):e278-e283. PubMed ID: 27682827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
